Cargando…

Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine

Proteome analysis of complex biological samples for biomarker identification remains challenging, among others due to the extended range of protein concentrations. High-abundance proteins like albumin or IgG of plasma and urine, may interfere with the detection of potential disease biomarkers. Curre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Filip, Szymon, Vougas, Konstantinos, Zoidakis, Jerome, Latosinska, Agnieszka, Mullen, William, Spasovski, Goce, Mischak, Harald, Vlahou, Antonia, Jankowski, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514849/ https://www.ncbi.nlm.nih.gov/pubmed/26208298 http://dx.doi.org/10.1371/journal.pone.0133773

Ejemplares similares

Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis
por: Latosinska, Agnieszka, et al.
Publicado: (2015)

Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis
por: Krochmal, Magdalena, et al.
Publicado: (2017)

Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease
por: Lygirou, Vasiliki, et al.
Publicado: (2018)

Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation
por: Chatziharalambous, Despina, et al.
Publicado: (2016)

Urine peptidome analysis in cardiorenal syndrome reflects molecular processes
por: Petra, Eleni, et al.
Publicado: (2021)

Glycosylation Analysis of Urinary Peptidome Highlights IGF2 Glycopeptides in Association with CKD
por: Lohia, Sonnal, et al.
Publicado: (2023)

Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of –omics findings
por: Latosinska, Agnieszka, et al.
Publicado: (2016)

PeptiCKDdb—peptide- and protein-centric database for the investigation of genesis and progression of chronic kidney disease
por: Krochmal, Magdalena, et al.
Publicado: (2016)

BcCluster: A Bladder Cancer Database at the Molecular Level
por: Bhat, Akshay, et al.
Publicado: (2016)

Collagen-Derived Peptides in CKD: A Link to Fibrosis
por: Mavrogeorgis, Emmanouil, et al.
Publicado: (2021)

Reviewing the Regulators of COL1A1
por: Devos, Hanne, et al.
Publicado: (2023)

Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation
por: Latosinska, Agnieszka, et al.
Publicado: (2020)

Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2018)

Author Correction: Urinary CE-MS peptide marker pattern for detection of solid tumors
por: Belczacka, Iwona, et al.
Publicado: (2019)

Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention
por: Latosinska, Agnieszka, et al.
Publicado: (2017)

Multiplexed MRM-based protein quantification of putative prognostic biomarkers for chronic kidney disease progression in plasma
por: Makridakis, Manousos, et al.
Publicado: (2020)

Reproducibility Evaluation of Urinary Peptide Detection Using CE-MS
por: Mavrogeorgis, Emmanouil, et al.
Publicado: (2021)

Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca(2+) signaling in T24M-based bladder cancer models
por: Frantzi, Maria, et al.
Publicado: (2016)

Protein Interactome of Muscle Invasive Bladder Cancer
por: Bhat, Akshay, et al.
Publicado: (2015)

Identification of ageing-associated naturally occurring peptides in human urine
por: Nkuipou-Kenfack, Esther, et al.
Publicado: (2015)

CD99 and polymeric immunoglobulin receptor peptides deregulation in critical COVID‐19: A potential link to molecular pathophysiology?
por: Siwy, Justyna, et al.
Publicado: (2021)

Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and Aggressiveness
por: Lygirou, Vasiliki, et al.
Publicado: (2022)

Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective
por: Lohia, Sonnal, et al.
Publicado: (2022)

Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination
por: Frantzi, Maria, et al.
Publicado: (2023)

Molecular Mapping of Urinary Complement Peptides in Kidney Diseases
por: Wendt, Ralph, et al.
Publicado: (2021)

Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease
por: Petra, Eleni, et al.
Publicado: (2022)

Gene Expression Monotonicity across Bladder Cancer Stages Informs on the Molecular Pathogenesis and Identifies a Prognostic Eight-Gene Signature
por: Stroggilos, Rafael, et al.
Publicado: (2022)

Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma
por: Voigtländer, Torsten, et al.
Publicado: (2020)

Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios
por: Keller, Felix, et al.
Publicado: (2023)

A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients’ Omics Signatures
por: Mokou, Marika, et al.
Publicado: (2020)

Urinary peptidomic profiles to address age-related disabilities: a prospective population study
por: Martens, Dries S, et al.
Publicado: (2021)

Proteomic Analysis of Mouse Kidney Tissue Associates Peroxisomal Dysfunction with Early Diabetic Kidney Disease
por: Tserga, Aggeliki, et al.
Publicado: (2022)

Downregulation of Salivary Proteins, Protective against Dental Caries, in Type 1 Diabetes
por: Pappa, Eftychia, et al.
Publicado: (2021)

Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis
por: Kontostathi, Georgia, et al.
Publicado: (2017)

Promise and Implementation of Proteomic Prostate Cancer Biomarkers
por: Latosinska, Agnieszka, et al.
Publicado: (2018)

Proteomic characterization of obesity-related nephropathy
por: Wendt, Ralph, et al.
Publicado: (2020)

Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease
por: Mokou, Marika, et al.
Publicado: (2019)

Evaluation of the Zucker Diabetic Fatty (ZDF) Rat as a Model for Human Disease Based on Urinary Peptidomic Profiles
por: Siwy, Justyna, et al.
Publicado: (2012)

Saliva Proteomics Analysis Offers Insights on Type 1 Diabetes Pathology in a Pediatric Population
por: Pappa, Eftychia, et al.
Publicado: (2018)

Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study
por: Jaimes Campos, Mayra Alejandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f9q22ccstce94mjvh2d7gm3e38